Stronger Sell Today UTHR ranks #3628 as SELL CANDIDATE #3628 Weaker Sell

UTHR stock forecast United Therapeutics Corporation

UTHR stock forecast





UTHR Forecast and Technical Stock Analysis

Sell candidate since 2019-07-03 Loss -7.06%

United Therapeutics Corporation gained 0.28% in the last trading day ( Wednesday, 17th Jul 2019 ), rising from $75.92 to $76.13 During day the stock fluctuated 1.97% from a day low at $75.45 to a day high of $76.94. The price has fallen in 8 of the last 10 days and is down by -8% for this period. Volume fell in the last day by -54 516 shares, and in total, 346 544 shares bought and sold for approximately $26.38 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Quick summary:

  • 30 day high of the UTHR stock price was $82.78 and low was $75.31.
  • 90 day high was $105.87 and low was $75.31.
  • 52 week high for the United Therapeutics Corporation - $130.00 and low - $75.31.
Top Trending Stocks


United Therapeutics Corporation lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -26.82% during the next 3 months and, with 90% probability hold a price between $49.65 and $57.44 at the end of this period.

Top Golden Star Stocks


A buy signal was issued from a pivot bottom point on Tuesday July 16, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. United Therapeutics Corporation holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $77.34 and $79.97. A break-up above any of these levels will issue buy signals.

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 49 and the stock is currently not being overbought or oversold

* uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Support & Resistance

United Therapeutics Corporation finds support from accumulated volume at $76.06.

Support: $76.06 Price: $76.13 Resistance: $78.60


This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.49 (1.97%) between high and low. For the last week, the stock has had a daily average volatility of 2.17%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

2.17 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Sell Candidate Upgraded


United Therapeutics Corporation holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Stronger Sell Today UTHR ranks #3628 as SELL CANDIDATE #3628 Weaker Sell

Will UTHR stock price go up or down on Fri, 19 Jul 2019?

Trading With Moving Average
As an investor, you always seek to understand what other... Full Article
Pivot Points
Pivot Points refer to points of significant change. As a... Full Article
Accumulated Volume - Support and Resistance
Volume is perhaps the best indicator of all and should... Full Article
Volume - The Indicator You Really Need to Know
Many new traders getting into the world of technical analysis... Full Article
We Give Back!
In 2016 donated to NGO Goodwill projects to help purchase medical... Full Article
Better Buy: Amazon vs. Facebook
Amazon's stock slipped 21% over the past six months, as... Full Article

Proudly made at